This company has been marked as potentially delisted and may not be actively trading. Longview Acquisition Corp. II (LGV) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock LGV vs. FMS, TMO, ISRG, EW, IDXX, ALC, DXCM, IQV, MTD, and STEShould you be buying Longview Acquisition Corp. II stock or one of its competitors? The main competitors of Longview Acquisition Corp. II include Fresenius Medical Care AG & Co. KGaA (FMS), Thermo Fisher Scientific (TMO), Intuitive Surgical (ISRG), Edwards Lifesciences (EW), IDEXX Laboratories (IDXX), Alcon (ALC), DexCom (DXCM), IQVIA (IQV), Mettler-Toledo International (MTD), and STERIS (STE). These companies are all part of the "med instruments" industry. Longview Acquisition Corp. II vs. Its Competitors Fresenius Medical Care AG & Co. KGaA Thermo Fisher Scientific Intuitive Surgical Edwards Lifesciences IDEXX Laboratories Alcon DexCom IQVIA Mettler-Toledo International STERIS Longview Acquisition Corp. II (NYSE:LGV) and Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, valuation, institutional ownership, dividends, media sentiment and earnings. Is LGV or FMS more profitable? Fresenius Medical Care AG & Co. KGaA has a net margin of 3.18% compared to Longview Acquisition Corp. II's net margin of 0.00%. Fresenius Medical Care AG & Co. KGaA's return on equity of 6.25% beat Longview Acquisition Corp. II's return on equity.Company Net Margins Return on Equity Return on Assets Longview Acquisition Corp. IIN/A N/A N/A Fresenius Medical Care AG & Co. KGaA 3.18%6.25%2.88% Do analysts prefer LGV or FMS? Fresenius Medical Care AG & Co. KGaA has a consensus price target of $27.80, suggesting a potential upside of 10.71%. Given Fresenius Medical Care AG & Co. KGaA's stronger consensus rating and higher probable upside, analysts plainly believe Fresenius Medical Care AG & Co. KGaA is more favorable than Longview Acquisition Corp. II.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Longview Acquisition Corp. II 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Fresenius Medical Care AG & Co. KGaA 1 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Do institutionals & insiders hold more shares of LGV or FMS? 8.4% of Fresenius Medical Care AG & Co. KGaA shares are owned by institutional investors. 26.4% of Longview Acquisition Corp. II shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Which has better valuation and earnings, LGV or FMS? Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Longview Acquisition Corp. II. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLongview Acquisition Corp. IIN/AN/AN/AN/AN/AFresenius Medical Care AG & Co. KGaA$20.63BN/A$582.08M$1.1222.42 Does the media refer more to LGV or FMS? In the previous week, Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 0.33 beat Longview Acquisition Corp. II's score of 0.00 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the news media. Company Overall Sentiment Longview Acquisition Corp. II Neutral Fresenius Medical Care AG & Co. KGaA Neutral SummaryFresenius Medical Care AG & Co. KGaA beats Longview Acquisition Corp. II on 9 of the 10 factors compared between the two stocks. Get Longview Acquisition Corp. II News Delivered to You Automatically Sign up to receive the latest news and ratings for LGV and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LGV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LGV vs. The Competition Export to ExcelMetricLongview Acquisition Corp. IIMED INSTRUMENTS IndustryMedical SectorNYSE ExchangeMarket CapN/A$6.70B$5.47B$20.63BDividend YieldN/A1.32%4.73%3.67%P/E RatioN/A20.9428.8929.01Price / SalesN/A54.70371.4465.92Price / CashN/A20.5035.4522.82Price / BookN/A4.468.264.43Net IncomeN/A$176.39M$3.25B$993.74M Longview Acquisition Corp. II Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LGVLongview Acquisition Corp. IIN/A$10.09flatN/AN/A$0.00N/A0.003High Trading VolumeFMSFresenius Medical Care AG & Co. KGaA3.5197 of 5 stars$26.41-1.3%$27.80+5.3%+33.8%$0.00$20.63B23.581,384TMOThermo Fisher Scientific4.9926 of 5 stars$478.61+0.8%$593.00+23.9%-25.6%$180.56B$43.21B27.68125,000Positive NewsAnalyst UpgradeISRGIntuitive Surgical4.7333 of 5 stars$495.86+1.5%$592.05+19.4%+7.1%$177.75B$8.35B69.1615,638Positive NewsInsider TradeEWEdwards Lifesciences4.4848 of 5 stars$79.92+5.4%$85.00+6.4%+28.2%$46.93B$5.44B11.5015,800Analyst UpgradeHigh Trading VolumeIDXXIDEXX Laboratories3.285 of 5 stars$565.19+2.8%$557.88-1.3%+12.1%$45.45B$3.93B52.2411,000Positive NewsUpcoming EarningsHigh Trading VolumeALCAlcon2.4425 of 5 stars$91.79-0.1%$106.13+15.6%-6.4%$45.31B$9.91B40.8025,599DXCMDexCom4.972 of 5 stars$88.99+2.6%$98.72+10.9%+12.7%$34.89B$4.15B66.4110,300Trending NewsEarnings ReportAnalyst ForecastInsider TradeAnalyst RevisionIQVIQVIA4.8593 of 5 stars$199.17-0.8%$228.62+14.8%-26.5%$33.86B$15.41B28.8288,000Positive NewsMTDMettler-Toledo International3.8412 of 5 stars$1,263.97+0.3%$1,280.90+1.3%-20.9%$26.27B$3.87B31.5217,300Trending NewsEarnings ReportSTESTERIS4.7687 of 5 stars$230.80+1.6%$270.33+17.1%-5.9%$22.67B$5.46B37.2317,787News CoveragePositive NewsUpcoming EarningsDividend Increase Related Companies and Tools Related Companies Fresenius Medical Care AG & Co. KGaA Competitors Thermo Fisher Scientific Competitors Intuitive Surgical Competitors Edwards Lifesciences Competitors IDEXX Laboratories Competitors Alcon Competitors DexCom Competitors IQVIA Competitors Mettler-Toledo International Competitors STERIS Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:LGV) was last updated on 8/2/2025 by MarketBeat.com Staff From Our Partners379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredI warned you about Nvidia… now look what’s happeningNvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before t...Timothy Sykes | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredDon’t Touch Tesla Stock Without Reading This FirstJeff Brown says he wouldn’t touch Tesla stock right now—and the reason might shock you. A 40-year Wall Stre...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Longview Acquisition Corp. II Please log in to your account or sign up in order to add this asset to your watchlist. Share Longview Acquisition Corp. II With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
